Based on their more dominant effects on PTEN level, we suggest that miR-26a and miR-92a might act as oncogenes in prostate cancer and play a more important role in co-regulation of the four miRNAs (Figure 9). The gene discussed is PTEN; the disease is prostate carcinoma.